Trial Profile
A Double-Blind, Placebo-Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of AVI-7100 in Healthy Subjects.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 17 Jul 2019
Price :
$35
*
At a glance
- Drugs Radavirsen (Primary)
- Indications Influenza A virus infections; Various toxicities
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Sarepta Therapeutics
- 10 Jun 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 21 Nov 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 21 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.